—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Twist Bioscience Corp (TWST) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for TWST, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 2.45 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How TWST has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 2.45 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Twist Bioscience Corp moved 2.45% on average · correlation 0.30 · higher than 100% of US names
  • Beta, last 3 months 2.74 more rate-sensitive lately than over the year
  • On the 10 worst bond days −0.16% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +16.11% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Biotechnology · US · 8 names with week and year-to-date

Peer group

Biotechnology · US

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against TWST on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Twist Bioscience Corp

TWST in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Twist Bioscience makes synthetic DNA to order, producing genes, gene fragments and oligo pools used in drug discovery, diagnostics, gene editing and data-storage research. It also sells sequencing tools such as library-preparation kits and exome panels, and viral reference controls used to build test assays. Customers include biotech, pharmaceutical, industrial and agricultural firms as well as academic labs. It is based in South San Francisco and listed in the United States.
Where it sits in the stack
Twist sits in the healthcare sector, within biotechnology, rather than in any Closelooknet index sleeve; it belongs to the diary's wider life-sciences coverage rather than the AI hardware stack.
Who it is priced against
The diary has no formal peer group for it yet; the market commonly places it alongside broader synthetic-biology and genomics-tools suppliers such as Thermo Fisher Scientific.
Why Closelooknet tracks it
Twist carries no Closelooknet index seat and no score in the diary yet, and it has not appeared in any Closelooknet edition or quote so far.
What the diary watches
Whether the stock's run well above its own recent trading range holds after analysts initiated coverage with a Sell rating, and how the shares behave near their prior high.

Twist Bioscience Corp (TWST) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: initiation by BWS Financial, 2026-09-09

The Street on this name

Analyst actions and the latest print for TWST from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation BWS Financial — at Sell Initiated to Sell 2026-09-09

1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst wire → · Earnings wire →

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Twist Bioscience Corp (TWST)?

Twist Bioscience Corp trades as TWST on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is TWST in a Closelooknet index?

Not currently — Twist Bioscience Corp is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does TWST trade against its moving averages?

Uptrend stack intact: Trades +44.8% vs the 50-day and +149.9% vs the 200-day average, 1.8% below the 52-week high and +684.7% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Twist Bioscience Corp trade when bond yields rise?

Over the past year Twist Bioscience Corp had a beta of 2.45 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 100% of US names. On the 10 sessions in which long bonds fell most it moved −0.16% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Twist Bioscience Corp do?

Twist Bioscience makes synthetic DNA to order, producing genes, gene fragments and oligo pools used in drug discovery, diagnostics, gene editing and data-storage research. It also sells sequencing tools such as library-preparation kits and exome panels, and viral reference controls used to build test assays. Customers include biotech, pharmaceutical, industrial and agricultural firms as well as academic labs. The diary has no formal peer group for it yet; the market commonly places it alongside broader synthetic-biology and genomics-tools suppliers such as Thermo Fisher Scientific.

Where does Twist Bioscience Corp sit in the AI build-out?

Twist sits in the healthcare sector, within biotechnology, rather than in any Closelooknet index sleeve; it belongs to the diary's wider life-sciences coverage rather than the AI hardware stack. Twist carries no Closelooknet index seat and no score in the diary yet, and it has not appeared in any Closelooknet edition or quote so far.

What has Wall Street done on Twist Bioscience Corp recently?

The most recent analyst action on Twist Bioscience Corp on the Closelooknet wire is a initiation by BWS Financial on 2026-09-09 (at Sell). 1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for TWST, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.